Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Jay D. who wrote (554)	11/18/1997 1:10:00 PM
From: george	Respond to of 1894

Jay, Wrong. Cytc makes a thin prep smear vs. the conventional smear..... Accumed can read either type of smear....if the thin prep smear if faulty, then it should not have an effect on Accumed....maybe even make it more valuable because the thin prep is easier to read than the conventional smear, and so if one goes back to the conventional Pap smear then one needs the Accumed system even more. Cytc is a type of smear. Accumed assists the cytologists to read smears. Neopath, etc. read smears automatically using computer artificial intelligence. Make sense? George